SECOND MODIFICATION AGREEMENTModification Agreement • June 4th, 2009 • Stem Cell Innovations, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 4th, 2009 Company Industry JurisdictionThis Second Modification Agreement (“Agreement”), dated as of May 29, 2009 is entered into by and among Stem Cell Innovations, Inc., a Delaware corporation (the “Company”), Margie Chassman (“Chassman”) and Alpha Capital Anstalt (“Alpha”).